(Q36901917)

17 August 2017

1 reference

title

Current trends in bacterial respiratory pathogens (English)

1 reference

17 August 2017

R. R. Facklam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1767804

19 November 2022

R. F. Breiman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1767804

19 November 2022

language of work or name

English

0 references

publication date

1 December 1991

1 reference

17 August 2017

30 December 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1767804

full work available at URL

19 November 2022

https://api.elsevier.com/content/article/PII:000293439190301D?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

https://api.elsevier.com/content/article/PII:000293439190301D?httpAccept=text/plain

19 November 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

American Journal of Medicine

19 November 2022

published in

1 reference

17 August 2017

volume

91

1 reference

17 August 2017

issue

6A

1 reference

17 August 2017

page(s)

3S-11S

1 reference

The epidemiology of pneumococcal disease in infants and children.

17 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups

19 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Serotypes of Streptococcus pneumoniae Causing Disease

19 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Clinical and epidemiologic studies of pneumococcal infection in children

19 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

A comparison of the distribution of pneumococcal types in systemic disease and the upper respiratory tract in adults and children

19 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Differences of pathophysiology in experimental meningitis caused by three strains of Streptococcus pneumoniae

19 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents

19 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

An outbreak of pneumococcal pneumonia in two men's shelters

19 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.

19 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly

19 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Pneumococcal vaccine: clinical efficacy and effectiveness

19 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Pneumococcal resistance to antibiotics

19 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Capsular types and antibiotic sensitivity of pneumococci isolated from patients with serious infections in Belgium 1980 to 1988.

19 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary.

19 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989

19 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan

19 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group

19 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Susceptibility of relatively penicillin-resistant Streptococcus pneumoniae to newer cephalosporin antibiotics.

19 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Susceptibility of penicillin-sensitive and -resistant strains of Streptococcus pneumoniae to new antimicrobial agents, including daptomycin, teicoplanin, cefpodoxime and quinolones.

19 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Pneumococcal bacteremia during ciprofloxacin therapy for pneumococcal pneumonia

19 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Pneumococcal meningitis during intravenous ciprofloxacin therapy

19 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin.

19 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Superinfection with Streptococcus pneumoniae during therapy with ciprofloxacin

19 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia

19 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Association of group C beta-hemolytic streptococci with endemic pharyngitis among college students

19 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Community-wide outbreak of group G streptococcal pharyngitis

19 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

The resurgence of acute rheumatic fever in the United States

19 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

The resurgence of group A streptococcal infections and their sequelae

19 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Apparent increase in the incidence of invasive group A beta-hemolytic streptococcal disease in children

19 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Changing epidemiology of group A streptococcal infection in the USA.

19 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Erythromycin resistance in group A streptococci

19 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

A community outbreak of group A beta haemolytic streptococci with transferable resistance to erythromycin

19 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centres.

19 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Cefadroxil versus penicillin in the treatment of streptococcal tonsillopharyngitis

19 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Five day treatment of pharyngotonsillitis with cefpodoxime proxetil

19 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Short-term treatment of streptococcal tonsillitis with ceftriaxone

19 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Comparative efficacy and toxicity of roxithromycin and erythromycin ethylsuccinate in the treatment of streptococcal pharyngitis in adults

19 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Clarithromycin versus penicillin in the treatment of streptococcal pharyngitis

19 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Corynebacterium hemolyticum as a cause of pharyngitis and scarlatiniform rash in young adults

19 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Selective medium for isolating Arcanobacterium haemolyticum

19 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Epidemiology of Haemophilus influenzae type b infections

19 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Prospective study of the aetiology and outcome of pneumonia in the community

19 November 2022

53

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Outbreak of multiresistant non-encapsulated Haemophilus influenzae infections in a pulmonary rehabilitation centre.

19 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Outbreaks of multiresistant Haemophilus influenzae infection

19 November 2022

56

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Haemophilus influenzae pneumonia in young adults with AIDS, ARC, or risk of AIDS.

19 November 2022

57

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Distribution and resistance patterns of Haemophilus influenzae: a European cooperative study

19 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae

19 November 2022

60

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States

19 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents.

19 November 2022

62

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

In-vitro activities of trospectomycin, cefpodoxime, and second-generation cephalosporins against Haemophilus influenzae type b

19 November 2022

63

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae

19 November 2022

64

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

In vitro activity of new antibiotics against Haemophilus influenzae.

19 November 2022

65

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

The comparative activity of lomefloxacin (SC-47111, NY-198) and other orally absorbable agents against Haemophilus influenzae and Branhamella catarrhalis

19 November 2022

66

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.

19 November 2022

67

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

In-vitro activity of clarithromycin combined with its 14-hydroxy metabolite A-62671 against Haemophilus influenzae

19 November 2022

68

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

The activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae, determined by in-vitro and serum bactericidal tests

19 November 2022

69

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Role of legionellae in acute infections of the lower respiratory tract

19 November 2022

70

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Prevalence and diagnosis of Legionella pneumonia: a 3-year prospective study with emphasis on application of urinary antigen detection

19 November 2022

71

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases

19 November 2022

72

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin

19 November 2022

74

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

The effects of single and combined antibiotics on the growth of Legionella pneumophila using time-kill studies.

19 November 2022

75

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions

19 November 2022

76

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

In vitro activity of azithromycin against clinical isolates of Legionella species

19 November 2022

77

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibiotics.

19 November 2022

78

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Bactericidal effects of amoxycillin/clavulanic acid against intracellular Legionella pneumophila in tissue culture studies

19 November 2022

79

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages

19 November 2022

80

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Bactericidal effects of amoxycillin/clavulanic acid against a Legionella pneumophila pneumonia in the weanling rat.

19 November 2022

81

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Rifampin resistance of Legionella pneumophila is not increased during therapy for experimental Legionnaires disease: study of rifampin resistance using a guinea pig model of Legionnaires disease

19 November 2022

82

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Mycoplasma pneumoniae pneumonia

19 November 2022

85

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Isolation of Mycoplasma pneumoniae from children with lower-respiratory-tract infections

19 November 2022

86

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Long-Term Epidemiology of Infections with Mycoplasma pneumoniae

19 November 2022

87

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Changes in the epidemiological pattern of Mycoplasma pneumoniae infections in Denmark. A 30 years survey

19 November 2022

88

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Extragenital Mycoplasma hominis infections in adults

19 November 2022

89

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Comparative susceptibility of Mycoplasma pneumoniae to erythromycin, ciprofloxacin, and lomefloxacin.

19 November 2022

92

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin

19 November 2022

93

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Efficacy of clarithromycin against Mycoplasma pneumoniae

19 November 2022

94

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Increase in resistance of Mycoplasma hominis to tetracyclines

19 November 2022

95

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases

19 November 2022

96

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Chlamydia pneumoniae, strain TWAR.

19 November 2022

97

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Chlamydia pneumoniae, strain TWAR, as the cause of an outbreak in a boys' school previously called psittacosis

19 November 2022

98

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Culture-confirmed pneumonia due to Chlamydia pneumoniae

19 November 2022

99

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Infection with Chlamydia pneumoniae in Brooklyn

19 November 2022

101

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Countrywide epidemics of Chlamydia pneumoniae, strain TWAR, in Scandinavia, 1981-1983.

19 November 2022

103

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

The seroepidemiology of Chlamydiae in Finland over the period 1971 to 1987

19 November 2022

104

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland

19 November 2022

105

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Isolation of Chlamydia pneumoniae from middle ear aspirates of otitis media with effusion: a case report

19 November 2022

107

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma

19 November 2022

108

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.

19 November 2022

109

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction

19 November 2022

110

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).

19 November 2022

112

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

The in-vitro antibiotic susceptibility of Chlamydia pneumoniae

19 November 2022

113

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections

19 November 2022

114

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Branhamella catarrhalis: an organism gaining respect as a pathogen

19 November 2022

117

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Branhamella catarrhalis in lower respiratory tract secretions in adults

19 November 2022

118

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Spectrum of disease due to Branhamella catarrhalis in children with particular reference to acute otitis media

19 November 2022

120

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum

19 November 2022

121

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Pharyngeal carriage of Moraxella (Branhamella) catarrhalis in healthy adults

19 November 2022

122

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Branhamella catarrhalis: phenotypic characteristics

19 November 2022

124

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.

19 November 2022

126

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Diphtheria in the United States, 1971-81

19 November 2022

127

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

An outbreak of diphtheria among Swedish alcoholics

19 November 2022

128

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Diphtheria: Incidence Trends and Age-wise Changes of Immunity

19 November 2022

129

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

The changing epidemiology of diphtheria in Jordan

19 November 2022

131

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Pertussis and its prevention: a family affair

19 November 2022

132

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology

19 November 2022

135

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin

19 November 2022

136

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

'Pertussis vaccine encephalopathy': it is time to recognize it as the myth that it is.

19 November 2022

137

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Antimicrobial susceptibility of Bordetella pertussis (Part I).

19 November 2022

138

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Treatment and prevention of pertussis by antimicrobial agents (Part II).

19 November 2022

139

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Bordetellae and charcoal horse blood agar: inactivation of antibiotics in agar during prolonged incubation for susceptibility testing

19 November 2022

140

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project

19 November 2022

141

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones

19 November 2022

142

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to six new oral cephalosporins

19 November 2022

143

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Adherence of streptococcus pyogenes, Escherichia coli, and Pseudomonas aeruginosa to fibronectin-coated and uncoated epithelial cells

19 November 2022

146

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Bacterial Pneumonia During the Hong Kong Influenza Epidemic of 1968-1969

19 November 2022

147

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza.

19 November 2022

148

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90301-D

19 November 2022

Identifiers

1 reference

17 August 2017

1 reference